U.S. markets closed
  • S&P 500

    3,465.39
    +11.90 (+0.34%)
     
  • Dow 30

    28,335.57
    -28.09 (-0.10%)
     
  • Nasdaq

    11,548.28
    +42.28 (+0.37%)
     
  • Russell 2000

    1,640.50
    +10.25 (+0.63%)
     
  • Crude Oil

    39.78
    -0.86 (-2.12%)
     
  • Gold

    1,903.40
    -1.20 (-0.06%)
     
  • Silver

    24.70
    -0.01 (-0.04%)
     
  • EUR/USD

    1.1868
    +0.0042 (+0.36%)
     
  • 10-Yr Bond

    0.8410
    -0.0070 (-0.83%)
     
  • GBP/USD

    1.3038
    -0.0042 (-0.32%)
     
  • USD/JPY

    104.7200
    -0.1200 (-0.11%)
     
  • BTC-USD

    12,954.82
    -357.31 (-2.68%)
     
  • CMC Crypto 200

    260.05
    -1.40 (-0.54%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • Nikkei 225

    23,516.59
    +42.32 (+0.18%)
     

Merck Inc (MRK) EVP, Global Svcs & CFO Robert M Davis Sold $20.4 million of Shares

GuruFocus.com
·1 min read

- By insider

EVP, Global Svcs & CFO of Merck Inc (30-Year Financial, Insider Trades) Robert M Davis (insider trades) sold 251,273 shares of MRK on 10/05/2020 at an average price of $81.03 a share. The total sale was $20.4 million.


Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Merck & Co Inc has a market cap of $201.4 billion; its shares were traded at around $79.63 with a P/E ratio of 19.40 and P/S ratio of 4.32. The dividend yield of Merck & Co Inc stocks is 3.06%.

CFO Recent Trades:

  • EVP, Global Svcs & CFO Robert M Davis sold 251,273 shares of MRK stock on 10/05/2020 at the average price of $81.03. The price of the stock has decreased by 1.73% since.

For the complete insider trading history of MRK, click here

.This article first appeared on GuruFocus.